Finance

Lists
600566:SHA
Hubei Jumpcan Pharmaceutical Co Ltd
CNÂ¥28.83
+0.45%
(+0.13) 1D
Nov 4, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600566...
Open
CNÂ¥28.53
High
CNÂ¥29.65
Low
CNÂ¥28.52
Mkt. cap
26.47B
Avg. vol.
6.90M
Volume
16.04M
Dividend
6.04%
Quarterly dividend
CNÂ¥0.44
Ex-dividend date
Jun 30, 2026
P/E ratio
14.63
52-wk high
CNÂ¥29.65
52-wk low
CNÂ¥21.13
EPS
CNÂ¥1.97
Shares outstanding
814.34M
No. of employees
4K
Open
CNÂ¥28.53
High
CNÂ¥29.65
Low
CNÂ¥28.52
Mkt. cap
26.47B
Avg. vol.
6.90M
Volume
16.04M
Dividend
6.04%
Quarterly dividend
CNÂ¥0.44
Ex-dividend date
Jun 30, 2026
P/E ratio
14.63
52-wk high
CNÂ¥29.65
52-wk low
CNÂ¥21.13
EPS
CNÂ¥1.97
Shares outstanding
814.34M
No. of employees
4K
News stories
From web sources and news partners
About Hubei Jumpcan Pharmaceutical Co Ltd
CEO-
Employees4.14K
FoundedJan 22, 1997
Headquarters-
SectorPharmaceutical industry
Industry-
Websitejumpcan.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.29B
1.21B
1.12B
1.31B
Cost of goods sold
376.60M
215.85M
264.37M
254.13M
Cost of revenue
376.60M
215.85M
264.37M
254.13M
Research and development expenses
113.25M
106.83M
102.34M
110.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
896.39M
531.31M
443.94M
534.67M
Operating expense
1.08B
604.29M
572.41M
703.67M
Total operating expenses
1.46B
820.14M
836.79M
957.80M
Operating income
827.18M
387.36M
284.03M
351.18M
Other non operating income
-5.35M
954.02K
-1.32M
86.48M
EBT including unusual items
901.85M
474.17M
457.68M
306.83M
EBT excluding unusual items
855.04M
454.87M
453.73M
412.46M
Income tax expense
147.70M
75.10M
74.73M
43.35M
Effective tax rate
16.38%
15.84%
16.33%
14.13%
Other operating expenses
45.61M
13.38M
22.69M
14.24M
Net income
755.39M
400.14M
384.08M
276.80M
Net profit margin
33.04%
33.14%
34.27%
21.15%
Earnings per share
-
-
-
-
Interest and investment income
35.26M
72.73M
178.07M
13.20M
Interest expense
-2.04M
-6.17M
-7.03M
-38.42M
Net interest expenses
33.23M
66.56M
171.04M
-25.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
901.97M
462.15M
361.71M
425.97M
Gain or loss from assets sale
-173.23K
-
-22.04K
22.04K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps